Our Company was originally incorporated at Delhi as "Wonder Fibromats Private Limited" on 13th October, 2009 under the provisions of the Companies Act, 1956 vide Certificate of Incorporation issued by the Asst. Registrar of Companies, NCT of Delhi & Haryana. Consequent, upon the conversion of our Company into public limited company, the name of our Company was changed to "Wonder Fibromats Limited" vide fresh certificate of incorporation dated 5th July, 2018 issued by the Registrar of Companies, Delhi. For further details of incorporation, change of name and registered office of our Company, please refer to chapter titled "General Information" and "Our History and Corporate Structure" beginning on pages 54 and page 148 respectively of the Prospectus.

INITIAL PUBLIC ISSUE OF 22,24,000 EQUITY SHARES OF A FACE VALUE OF RS. 10/- EACH (THE "EQUITY SHARES") OF WONDER FIBROMATS LIMITED ("OUR COMPANY" OR "WFL" OR "THE ISSUER") FOR CASH AT A PRICE OF RS. 89/- PER EQUITY SHARE (INCLUDING A SHARE PREMIUM OF RS. 79 PER EQUITY SHARE) ("ISSUE PRICE") AGGREGATING TO RS. 1,979.36 LAKHS ("THE ISSUE") OF WHICH 1,12,000 EQUITY SHARES AT AN ISSUE PRICE OF RS. 89 PER EQUITY SHARE AGGREGATING TO RS. 99.68 LAKHS WILL BE RESERVED FOR SUBSCRIPTION BY MARKET MAKER ("MARKET MAKER RESERVATION PORTION"). THE ISSUE LESS THE MARKET MAKER RESERVATION PORTION I.E. ISSUE OF 21,12,000 EQUITY SHARES OF FACE VALUE OF RS. 10.00 EACH AT AN ISSUE PRICE OF RS. 89 PER EQUITY SHARE AGGREGATING TO RS. 1,879.68 LAKHS IS HEREINAFTER REFERRED TO AS THE "NET ISSUE". THE ISSUE AND THE NET ISSUE WILL CONSTITUTE 26.55% AND 25.22%, RESPECTIVELY OF THE POST ISSUE PAID UP EQUITY SHARE CAPITAL OF OUR COMPANY.

*The Company in consultation with the Lead Manager decided to revise the price band to Rs. 89 from the initial price band of Rs. 90 in terms of the SEBI Regulations. On account of such revision, the Bid/Issue Period was extended by three working days and consequently the Bid/Issue closed on July 29, 2019 as compared to the earlier scheduled Bid/Issue Closing Date of July 24, 2019. The prescribed advertisement in this regard was published in all editions of English national daily newspaper Financial Express, Hindi national daily newspaper Jansatta on July 25 2019, where the pre-issue advertisement was published.

The Equity Shares of the Company are proposed to be listed on the EMERGE Platform of NSE ("NSE") in terms of the Regulation 281 read with Regulation 103(1) of the SEBI (ICDR) Regulations. 2018 as amended from time to time. Our Company has received an In-Principal approval from NSE for the listing of the Equity Shares pursuant to letter dated November 13, 2018. NSE shall be the Designated Stock Exchange for the purpose of this Issue. The trading is proposed to be commenced on August 06, 2019 (Subject to receipt of listing and trading approvals from the National Stock Exchange of India Limited).

The Issue is being made through the Fixed Price process, the allocation in the Net Issue to the Public category shall be made pursuant to Regulation 281 read with Regulation 129(4) and Regulation 253(2) of the SEBI (ICDR) Regulations, 2018, as amended from time to time, wherein a minimum of 50% of the Net Issue of shares to the Public shall initially be made available for allotment to Retail Individual Investors. The balance of Net Issue of Shares to the public shall be made available for allotment to Individual Applicants other than Retail Individual Investors and other Investors, including Corporate Bodies / Institutions irrespective of number of shares applied for. If the Retail Individual Investor category is entitled to more than 50% on proportionate basis, they shall be allotted that higher percentage. Under subscription, if any, in any of the categories, would be allowed to be met with spill-over from any of the other categories or a combination of categories at the discretion of our Company in consultation with the Lead Manager and the Designation Stock Exchange. Such inter-se spill over, if any, would be affected in accordance with applicable laws, rules, regulations and guidelines. All Investors except underwriter procured applicant have participated in the Issue through APPLICATIONS SUPPORTED BY BLOCKED AMOUNT ("ASBA") process by providing the details of their respective bank accounts in which the corresponding application amounts were blocked by Self Certified Syndicate Banks (the "SCSBs").

SUBSCRIPTION DETAILS

The Issue has received 319 applications for 27,80,800 Equity Shares (Including Market Maker Application of 1,12,000 Equity Shares) resulting 1.250 times subscription. Three (3) applications of aggregating 1,10,400 Equity Shares were tendered invalid as multiple application and Twenty One (21) applications of aggregating 4,40,000 Equity Shares v/ere not banked. Hence 295 applications for 22,30,400 Equity Shares (Including Market Maker application of 1,12,000 Equity Shares) resulting 1.003 times subscription was considered. The details of the applications received in the Issue (before technical rejections) are as follows:

Detail of the Applications Received (Before Technical Rejection & withdrawal of application):

The details of applications rejected by the Registrar on technical grounds are detailed below:

After considering the technical rejection of 32,000 Equity Shares, 289 applications for 21,98,400 Equity Shares (Including Market Maker application of 1,12,000 Equity Shares) resulting 0.988 times subscription was considered and thereby creating a shortfall of 25,600 Equity Shares. Hence Underwriters have arranged for the shortfall of 25,600 Equity Shares through one investor and accordingly issue was subscribed to 1.000 time.

Details of the Valid Applications Received (After Technical Rejection & Underwriter Procured Application):

ALLOCATION: The Basis of Allotment was finalized in consultation with the Designated Stock Exchange - National Stock Exchange of India Limited on 1st August, 2019.

A. Allocation to Market Maker (After Technical Rejections & Withdrawal): The Basis of Allotment to the Market Maker, at the Issue price of Rs. 89/- per Equity Share, was finalized in consultation with NSE. The category was subscribed by 1.000 time. The total number of shares allotted in this category is 1,12,000 Equity shares in full out of reserved portion of 1,12,000 Equity Shares.

B. Allocation to Retail Individual Investors (After Technical Rejections & Withdrawal): The Basis of Allotment to the Retail Individual Investors, at the Issue price of Rs. 89/- per Equity Share, was finalized in consultation with NSE. The category was subscribed by 0.321 times. Total number of shares allotted in this category is 3,39,200 Equity Shares against reserved portion of 10,56,000 Equity Shares and balance 7,16,800 Equity Shares were spilled over to Non Retail Category. The category wise basis of allotment is as under:

C. Allocation to Non Retail Investors (After Technical Rejections & Withdrawal): The Basis of Allotment to the Non Retail Investors, at the Issue price of Rs. 89/- per Equity Share, was finalized in consultation with NSE. The category was subscribed by 1.654 times. Total number of shares allotted in this category is 17,47,200 Equity Shares against available Equity Shares of 17,72,800 Equity Shares including spill over of 7,16,800 Equity Shares from Retail Category. The shortfall of 25,600 Equity Shares has been subscribed by investor procured through Underwriters. The category wise basis of allotment is as under:

D. Allocation to Underwriter-Procured Investor: The Basis of Allotment to the Underwriter-Procured Investor, at the Issue price of Rs. 89/- per Equity Share, was finalized in consultation with NSE. Total number of shares allotted in this category is 25,600 Equity Shares in order to subscribe the unsubscribed portion of 25,600 equity shares. After eliminating the cheque returns and technical rejections, the valid subscription was aggregating to 21,98,400 equity shares hence causing shortfall of 25,600 shares equity shares. In terms of the underwriting agreement the Underwriters procured the investor, accordingly one (1) application for 25,600 equity shares was towards full filling their underwriting obligation and the same has been considered for processing and included in Non-Institutional category.

The Board of Directors of the Company at its meeting held on August 02, 2019, has taken on record the Basis of Allotment of Equity Shares, as approved by the Designated Stock Exchange viz. NSE and has authorized the corporate action for the allotment of the Equity Shares to various successful applicants.

The CAN and allotment advice and / or notices shall be dispatched to the address of the investors as registered with the depositories on or before August 5, 2019. Further, the instructions to Self Certified Syndicate Banks will be processed on or before August 5, 2019 for unblocking of funds. The Equity Shares allotted to successful applicants are being credited to their beneficiary accounts subject to validation of the account details with the depositories concerned. In case the same is not received within prescribed time, investors may contact the Registrar to the Issue at the address given below. The Company is taking steps to get the Equity Shares admitted for trading on the EMERGE Platform of NSE within 6 working days from the Closure of the Issue. The trading is proposed to be commenced on August 06, 2019 subject to receipt of listing and trading approvals from National Stock Exchange of India Limited.

Note: All capitalized terms used and not defined herein shall have the respective meanings assigned to them in the Prospectus dated July 02, 2019 ("Prospectus").

INVESTORS PLEASE NOTE

The details of the allotment made has been hosted on the website of the Registrar to the Issue, KARVY FINTCH PRIVATE LIMITED at Website: https://karisma.karvy.com All future correspondence in this regard may kindly be addressed to the Registrar to the Issue quoting full name of the First/Sole Applicant, Serial number of the Application Form, Number of Shares Applied for and Bank Branch where the Application had been lodged and payment details at the address given below:

	KARVY FINTECH PRIVATE LIMITED
	Karvy Selenium Tower B, Plot 31 -32, Gachibowli, Financial District, Nanakramguda, Hyderabad 500 032
	Tel: +91 4067162222
	Fax: +914023431551
	Website: https://Xarisma.karvy.com
	E-mail: einward.ris@karvy.com
	Investor Grievance E-mail: wonderfibromats.ipo@karvy.com
	Contact Person: Mr. M Murali Krishna
	SEBI Registration: INR000000221

WONDER FIBROMATS LIMITED is proposing, subject to applicable statutory and regulatory requirements, receipt of requisite approvals, market conditions and other considerations, to make a Public Issue of its Equity Shares and has filed the Prospectus with the Registrar of Companies, Uttar Pradesh. The Prospectus shall be available on the websites of the Company, the NSE and the Lead Manager at www.wonderfibromats.com, www.nseindia.com/emerge and www.navigantcorp.com respectively. Applicants should note that investment in equity shares involves a high degree of risk and for details relating to the same, see the Prospectus, including, the section titled "Risk Factors" beginning on page no. 25 of the Prospectus.

The Equity Shares have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "U.S. Securities Act"), and may not be offered or sold within the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the U.S. Securities Act and applicable U.S. state securities laws. Accordingly, the Equity Shares are being offered and sold (i) within the United States to persons reasonably believed to be qualified institutional investors (as defined in Rule 144A under the U.S. Securities Act) pursuant to Rule 144A under the U.S. Securities Act and (ii) outside the United States in offshore transactions in reliance on Regulation S under the U.S. Securities Act and applicable laws of the jurisdictions where such offers and sales occur.